These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35006518)

  • 21. Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies.
    Chapman WD; Herink MC; Cameron MH; Bourdette D
    Curr Neurol Neurosci Rep; 2023 Sep; 23(9):521-529. PubMed ID: 37523105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus.
    Tan ECK; Sluggett JK; Johnell K; Onder G; Elseviers M; Morin L; Vetrano DL; Wastesson JW; Fastbom J; Taipale H; Tanskanen A; Bell JS;
    J Am Med Dir Assoc; 2018 Mar; 19(3):193-199. PubMed ID: 29361432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of deprescribing for older people with frailty and polypharmacy: part one.
    Lyne S
    Nurs Older People; 2023 Oct; 35(5):35-41. PubMed ID: 37670533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 26. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translation and cultural adaptation of MedStopper®-A web-based decision aid for deprescribing in older adults: A protocol.
    Monteiro L; Baptista S; Ribeiro-Vaz I; McCormack J; Matos C; Teixeira A; Monteiro-Soares M; Martins C
    PLoS One; 2023; 18(4):e0284464. PubMed ID: 37079629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing polypharmacy through medication review tools - pros and cons.
    Gavazova E; Staynova R; Grekova-Kafalova D
    Folia Med (Plovdiv); 2024 Apr; 66(2):161-170. PubMed ID: 38690810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients.
    Duncan I; Maxwell TL; Huynh N; Todd M
    Am J Hosp Palliat Care; 2020 Dec; 37(12):1076-1085. PubMed ID: 32662276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational deprescribing in the elderly.
    Williams S; Miller G; Khoury R; Grossberg GT
    Ann Clin Psychiatry; 2019 May; 31(2):144-152. PubMed ID: 31046036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing and deprescribing in chronic kidney disease.
    Manski-Nankervis JA; McMorrow R; Nelson C; Jesudason S; Sluggett JK
    Aust J Gen Pract; 2021 Apr; 50(4):183-187. PubMed ID: 33786539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks.
    McDonald EG; Lundby C; Thompson W; Boyd C; Farrell B; Gagnon C; Herbin J; Khuong N; Moriarty F; Pierson T; Scott S; Scott IA; Silvius J; Spinewine A; Steinman MA; Tannenbaum C; Trimble J; Turner JP; Reeve E
    Expert Rev Clin Pharmacol; 2024; 17(5-6):433-440. PubMed ID: 38739460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polypharmacy and deprescribing in cardiology].
    Bobbio M
    G Ital Cardiol (Rome); 2020 Oct; 21(10):801-806. PubMed ID: 32968317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoughtful Prescribing and Deprescribing.
    Pravodelov V
    Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.